The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Honoraria - AstraZeneca; Boehringer Ingelheim; Chugai Pharma; MSD; Roche
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; AstraZeneca (Inst); Bayer; Boehringer Ingelheim; Boehringer Ingelheim (Inst); Bristol-Myers Squibb; Celgene; Clovis Oncology; Lilly; Merck Serono; MSD Oncology; Novartis; Ono Pharmaceutical; Pfizer; Roche/Genentech
 
Consulting or Advisory Role - ARIAD; AstraZeneca; Pfizer; Roche
Speakers' Bureau - AstraZeneca; Boehringer Ingelheim; Roche
Research Funding - ARIAD; AstraZeneca; Boehringer Ingelheim; Clovis Oncology; Daiichi Sankyo; Igenica; Pfizer
Cumulative incidence rates for CNS and non-CNS progression by baseline CNS metastases status using data from two alectinib phase II studies.
 
Shirish M. Gadgeel
Consulting or Advisory Role - ARIAD; AstraZeneca; Boehringer Ingelheim; Genentech/Roche; Novartis; Pfizer
Speakers' Bureau - Genentech/Roche
Research Funding - ACEA Biosciences (Inst); Acerta Pharma (Inst); AstraZeneca/MedImmune (Inst); Bristol-Myers Squibb (Inst); Clovis Oncology (Inst); Five Prime Therapeutics (Inst); Genentech/Roche (Inst); Halozyme (Inst); Incyte (Inst); Janssen Oncology (Inst); Merck (Inst); Millennium (Inst); Novartis (Inst); OncoMed (Inst); Pfizer (Inst)
 
Alice Tsang Shaw
Honoraria - Novartis; Pfizer; Roche/Genentech
Consulting or Advisory Role - ARIAD; Blueprint Medicines; Daiichi Sankyo; EMD Serono; Genentech; Ignyta; Novartis; Pfizer; Roche; Taiho Pharmaceutical
Research Funding - Novartis; Pfizer; Roche/Genentech
 
Fabrice Barlesi
Consulting or Advisory Role - Novartis; Pfizer; Roche
 
Lucio Crino
Speakers' Bureau - AstraZeneca; Bristol-Myers Squibb; Novartis
 
James Chih-Hsin Yang
No Relationships to Disclose
 
Anne-Marie C. Dingemans
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; Lilly; MSD; Pfizer
Speakers' Bureau - Roche
 
Dong-Wan Kim
No Relationships to Disclose
 
Filippo De Marinis
No Relationships to Disclose
 
Mathias Schulz
Employment - Genentech
Stock and Other Ownership Interests - Roche
 
Shiyao Liu
Employment - Genentech
Stock and Other Ownership Interests - Roche
Travel, Accommodations, Expenses - Roche
 
Susan Meredith Fish
Employment - Genentech/Roche
Stock and Other Ownership Interests - Roche
 
Ahmed Kotb
Employment - Roche
Stock and Other Ownership Interests - Roche
Honoraria - Roche
Consulting or Advisory Role - Roche
 
Sai-Hong Ignatius Ou
No Relationships to Disclose